Clinical trial
Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative…
NCT00303615 · Legacy Health System, Other · Terminated
Key facts
| NCT number | NCT00303615 |
|---|---|
| Title | Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer |
| Official title | Androgen Therapy for Management of Estrogen/Progesterone Receptor Negative ER(-)PR(-) Metastatic Breast Cancer, Phase II Study |
| Lead sponsor | Legacy Health System, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Breast Cancer |
| Intervention type | Drug |
| Interventions | Fluoxymesterone 10 mg, Anastrozole 1 mg |
| Enrollment | 5 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Mar 17, 2006 |
| Last update posted | Oct 20, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: